• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例北美使用柏林心脏 EXCOR 主动泵驱动的经验。

First North American experience with the Berlin Heart EXCOR Active driver.

机构信息

Department of Pediatric Cardiology, University of Alberta, Edmonton, Alberta, Canada; Division of Pediatric Cardiology, Stollery Children's Hospital, Edmonton, Alberta, Canada.

Division of Pediatric Cardiology, Stollery Children's Hospital, Edmonton, Alberta, Canada.

出版信息

J Heart Lung Transplant. 2024 Nov;43(11):1861-1863. doi: 10.1016/j.healun.2024.08.005. Epub 2024 Aug 10.

DOI:10.1016/j.healun.2024.08.005
PMID:39134164
Abstract

For smaller pediatric patients on ventricular assist devices, the Berlin Heart EXCOR remains the main form of durable support. It requires a connection to the external IKUS, which has limited portability and battery life. The new EXCOR Active mobile driving unit has a battery life of up to 13 hours. We describe the first North American experience with the EXCOR Active in pediatric patients with a Berlin Heart device. A retrospective chart review was undertaken. Between October 2022 and March 2024, 7 patients were on a Berlin Heart and supported with the EXCOR Active. All patients were initially supported with the IKUS with a median time to transition to the EXCOR Active of 12.0 days (interquartile range [IQR] 9.5, 18.5) and a median time of support with the EXCOR Active of 65.0 days (IQR, 32.0, 81.0). The EXCOR Active posed no significant safety issues, and minimal operating issues were noted. Following the transition from IKUS to the EXCOR Active, there was increased patient and caregiver mobility throughout the hospital. Use of the EXCOR Active has the potential to improve the quality of life in pediatric patients waiting for heart transplantation.

摘要

对于使用心室辅助设备的小型儿科患者,Berlin Heart EXCOR 仍然是主要的持久支持形式。它需要与外部的 IKUS 连接,而 IKUS 的便携性和电池寿命有限。新型 EXCOR Active 移动驱动单元的电池寿命最长可达 13 小时。我们描述了在使用 Berlin Heart 设备的儿科患者中首次使用 EXCOR Active 的北美经验。进行了回顾性图表审查。在 2022 年 10 月至 2024 年 3 月期间,有 7 名患者使用 Berlin Heart 并接受了 EXCOR Active 的支持。所有患者最初均通过 IKUS 进行支持,从过渡到 EXCOR Active 的中位时间为 12.0 天(四分位距 [IQR] 9.5,18.5),使用 EXCOR Active 的中位时间为 65.0 天(IQR,32.0,81.0)。EXCOR Active 没有带来重大安全问题,仅注意到一些轻微的操作问题。从 IKUS 过渡到 EXCOR Active 后,患者和照顾者在整个医院的移动性得到了提高。使用 EXCOR Active 有可能提高等待心脏移植的儿科患者的生活质量。

相似文献

1
First North American experience with the Berlin Heart EXCOR Active driver.首例北美使用柏林心脏 EXCOR 主动泵驱动的经验。
J Heart Lung Transplant. 2024 Nov;43(11):1861-1863. doi: 10.1016/j.healun.2024.08.005. Epub 2024 Aug 10.
2
Berlin Heart EXCOR and ACTION post-approval surveillance study report.柏林心脏 EXCOR 和 ACTION 上市后监测研究报告。
J Heart Lung Transplant. 2021 Apr;40(4):251-259. doi: 10.1016/j.healun.2021.01.010. Epub 2021 Jan 19.
3
Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale.柏林心脏 EXCOR 小儿心室辅助装置研究:研究设计与原理。
Am Heart J. 2011 Sep;162(3):425-35.e6. doi: 10.1016/j.ahj.2011.05.026. Epub 2011 Jul 30.
4
The Berlin Heart EXCOR Pediatric ventricular assist device: history, North American experience, and future directions.柏林心脏 EXCOR 小儿心室辅助装置:历史、北美经验和未来方向。
Ann N Y Acad Sci. 2013 Jul;1291:96-105. doi: 10.1111/nyas.12144. Epub 2013 Jun 10.
5
Biventricular Berlin Heart EXCOR pediatric use across the united states.双心室柏林心脏EXCOR在美国的儿科应用。
Ann Thorac Surg. 2015 Apr;99(4):1328-34. doi: 10.1016/j.athoracsur.2014.09.078. Epub 2015 Feb 20.
6
Outcomes of Berlin Heart EXCOR pediatric ventricular assist device support in patients with restrictive and hypertrophic cardiomyopathy.柏林心脏EXCOR小儿心室辅助装置对限制型和肥厚型心肌病患者的支持效果。
Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13048. Epub 2017 Sep 14.
7
Neurological complications and outcomes in the Berlin Heart EXCOR® pediatric investigational device exemption trial.柏林心脏EXCOR®儿科研究器械豁免试验中的神经并发症及结果
J Am Heart Assoc. 2015 Jan 22;4(1):e001429. doi: 10.1161/JAHA.114.001429.
8
Preliminary single center North American experience with the Berlin Heart pediatric EXCOR device.北美单中心使用柏林心脏小儿EXCOR设备的初步经验。
ASAIO J. 2008 Sep-Oct;54(5):479-82. doi: 10.1097/MAT.0b013e318184e200.
9
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.柏林心脏公司 EXCOR 儿科心室辅助装置在美国儿童中用于心脏移植桥接。
Circulation. 2013 Apr 23;127(16):1702-11. doi: 10.1161/CIRCULATIONAHA.112.000685. Epub 2013 Mar 28.
10
A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device--the United Kingdom experience.一场更长的等待之旅:使用柏林心EXCOR设备助力儿童等待心脏移植——英国的经验
J Heart Lung Transplant. 2013 Nov;32(11):1101-6. doi: 10.1016/j.healun.2013.08.003. Epub 2013 Sep 21.

引用本文的文献

1
Improving pediatric heart failure outcomes through collaboration and innovation: The current status of the Advanced Cardiac Therapies Improving Outcomes Network (ACTION).通过合作与创新改善小儿心力衰竭治疗效果:先进心脏治疗改善预后网络(ACTION)的现状
JHLT Open. 2025 Jun 2;9:100311. doi: 10.1016/j.jhlto.2025.100311. eCollection 2025 Aug.
2
The Introduction of a New Mobile Driving Unit for a Ventricular Assist Device in a Pediatric Patient (EXCOR Active).一名儿科患者(EXCOR Active)使用心室辅助装置的新型移动驱动单元介绍。
J Cardiovasc Dev Dis. 2024 Dec 7;11(12):392. doi: 10.3390/jcdd11120392.